EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Automation and Active Learning for the Multi‐Objective Optimization of Antibody Formulations

D Christopher Radford, Matthew Tamasi, Elena Di Mare, Adam J Gormley iD

Advanced Science · 2026

DOI: 10.1002/advs.76551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von D Christopher Radford und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA. Hauptthemen laut MEDLINE: Machine Learning, Antibodies, Monoclonal, Automation, Chemistry, Pharmaceutical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Science Foundation, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the last forty years, monoclonal antibodies have become increasingly important therapeutic agents, with most manufactured as preformulated solutions. However, bioformulation of complex proteins is a difficult engineering challenge; formulations must be tailored to individual therapies, necessitating time‐ and material‐intensive campaigns to select combinations of excipients to simultaneously optimize various design criteria. These additives complicate formulation design with unintuitive and non‐linear relationships, creating a vast multidimensional design space that is intrinsically difficult to optimize using traditional techniques. To address this challenge, we investigated a high‐throughput discovery pipeline using machine learning to model and predict the effects of GRAS excipients on formulation behavior of a model antibody. This was supported by automation‐assisted “on‐demand” formulation to produce dozens of uniquely formulated antibody solutions for downstream evaluation and biophysical characterization. This pipeline was then integrated into an iterative closed‐loop cycle of automated Design‐Build‐Test‐Learn (DBTL), where new rounds of experiments are designed by the model. The process yielded both improved formulations and accurate predictive models of formulation behavior across multiple target objectives (melting temperature, diffusivity, and high‐concentration viscosity). This validates the utility of this technique to both map the underlying property‐function landscape and effectively guide formulation development while balancing multiple competing design requirements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningAntibodies, MonoclonalAutomationChemistry, PharmaceuticalExcipientsDrug CompoundingHumans

Stichwörter der Autor:innen

GRAS excipientsbayesian optimizationbiologicsmachine learningprotein formulation

Substanzen

Antibodies, MonoclonalExcipients

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.

ORCID-Profile: Adam J Gormley

Förderung

  • NIGMS NIH HHS
  • National Science Foundation
  • NIH HHS
  • NIBIB NIH HHS
  • National Institutes of Health

Zitieren

APA

Radford, D. C., Tamasi, M., Di Mare, E., & Gormley, A. J. (2026). Automation and Active Learning for the Multi‐Objective Optimization of Antibody Formulations. Advanced Science. https://doi.org/10.1002/advs.76551

Vancouver

Radford DC, Tamasi M, Di Mare E, Gormley AJ. Automation and Active Learning for the Multi‐Objective Optimization of Antibody Formulations. Advanced Science. 2026. doi:10.1002/advs.76551

BibTeX
@article{Radford2026,
  author = {Radford, D Christopher and Tamasi, Matthew and Di Mare, Elena and Gormley, Adam J},
  title = {Automation and Active Learning for the Multi‐Objective Optimization of Antibody Formulations},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76551}
}
Kostenlos starten →